|
業務類別
|
Biotechnology |
|
業務概覽
|
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. |
| 公司地址
| Zernikedreef 9, Leiden, ZH, NLD, 2333 CK |
| 電話號碼
| +31 881667000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.proqr.com |
| 員工數量
| 166 |
| Mr. Jurriaan Dekkers |
Chief Financial Officer |
-- |
13/03/2025 |
| Mr. Rene Beukema |
Executive Director, Chief Corporate Development Officer and General Counsel |
-- |
13/03/2025 |
| Dr. Gerard Platenburg, PhD |
Chief Scientific Officer and and Executive Director |
-- |
13/03/2025 |
| Mr. Daniel de Boer |
Chief Executive Officer and Executive Director |
-- |
13/03/2025 |
| Ms. Sheila Sponselee |
Chief People and Operations Officer |
-- |
13/03/2025 |
|
|
| Dr. Martin Maier, PhD |
Independent Director |
13/03/2025 |
| Mr. Rene Beukema |
Executive Director, Chief Corporate Development Officer and General Counsel |
13/03/2025 |
| Dr. Begona Carreno, PhD |
Independent Director |
13/03/2025 |
| Dr. Gerard Platenburg, PhD |
Chief Scientific Officer and and Executive Director |
13/03/2025 |
| Mr. Daniel de Boer |
Chief Executive Officer and Executive Director |
13/03/2025 |
| Dr. Dinko Valerio, PhD |
Independent Director |
13/03/2025 |
| Ms. Alison F. Lawton |
Independent Director |
13/03/2025 |
| Mr. Bart Filius, M.B.A. |
Independent Director |
13/03/2025 |
| Dr. James S. Shannon, M.D.,M.R.C.P. |
Chairman of the Board |
13/03/2025 |
| Ms. Theresa M. Heggie |
Independent Director |
13/03/2025 |
|
|
|
|
